Evidence map›Paper›PMID 40201179›Full record

ArticleFrontiers in immunology2025

Prediction model of gastrointestinal tumor malignancy based on coagulation indicators such as TEG and neural networks.

Fulong Yu, Chudi Sun, Liang Li, Xiaoyu Yu, Shumin Shen, Hao Qiang, Song Wang, Xianghua Li, Lin Zhang, Zhining Liu

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Fulong Yu *Department of General Surgery, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Chudi Sun *School of Computer Science and Technology, Soochow University, Suzhou, Jiangsu, China.
Liang Li *Department of General Surgery, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Xiaoyu YuClinical Pharmacy, School of Pharmacy, Wannan Medical College, Wuhu, Anhui, China.
Shumin ShenDepartment of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Hao QiangDepartment of General Surgery, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Song WangDepartment of General Surgery, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Xianghua Li *Department of Molecular Pathology, Hefei Da'an Medical Laboratory Co., Ltd., Hefei, Anhui, China.
Lin Zhang *The School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Zhining Liu *Department of General Surgery, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Accurate determination of gastrointestinal tumor malignancy is a crucial focus of clinical research. Constructing coagulation index models using big data is feasible to achieve this goal. This study builds various prediction models through machine learning methods based on the different coagulation statuses under varying malignancy levels of gastrointestinal tumors. The aim is to use coagulation indicators to predict the malignancy of gastrointestinal tumors, expand the methods and ideas for coagulation index tumor prediction, and identify independent risk factors for gastrointestinal tumor malignancy. Methods: Clinical data of 300 patients with gastrointestinal diseases were collected from the Second Affiliated Hospital of Anhui Medical University from January 2024 to August 2024 and grouped according to TNM and G staging, representing tumor malignancy levels. First, independent influencing factors of gastrointestinal tumor malignancy were identified using stepwise multivariate logistic regression. ROC curves were used to assess the ability of TEG five items and other coagulation indicators to distinguish between malignancy levels of gastrointestinal tumors. Finally, we constructed a network model suitable for our task data based on residual networks, named the Residual Fully Connected Binary Classifier (RFCBC). This model was compared with other commonly used binary classification methods to select the optimal model. Results: The TEG five items (AUC values: R: 0.682; K: 0.731; α-angle: 0.736; MA: 0.699; CI: 0.747) showed better discrimination ability in the G group than other coagulation indicators. Although the TNM group showed moderate discrimination ability, it did not exhibit a significant advantage over other indicators. The R and MA values were identified as independent influencing factors in both TNM and G groups. Ultimately, the RFCBC prediction model showed the best predictive performance compared to other binary classification machine learning models (TEG five items: 87.56%; Thromboelastogram et al.: 88.6%). Conclusion: This study found that the R and MA values are independent predictive factors for the malignancy of gastrointestinal tumors. Compared to other coagulation indicators, the TEG five items have better discrimination ability regarding tumor malignancy. The RFCBC model created in this study outperforms other commonly used binary classification methods in predicting the malignancy of gastrointestinal tumors, providing a new model construction method and feasible approach for future coagulation index prediction of gastrointestinal tumor malignancy.

Indexed as

Blood CoagulationGastrointestinal NeoplasmsNeural Networks, ComputerThrombelastographyAdultAgedFemaleHumansMachine LearningMaleMiddle AgedPrognosisRisk FactorsROC Curvecoagulation indicatorscolorectal cancergastric cancermachine learningpredictive modelsTEG

Identifiers

PMID40201179
PMCPMC11975555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.